JPS6340766B2 - - Google Patents
Info
- Publication number
- JPS6340766B2 JPS6340766B2 JP54097006A JP9700679A JPS6340766B2 JP S6340766 B2 JPS6340766 B2 JP S6340766B2 JP 54097006 A JP54097006 A JP 54097006A JP 9700679 A JP9700679 A JP 9700679A JP S6340766 B2 JPS6340766 B2 JP S6340766B2
- Authority
- JP
- Japan
- Prior art keywords
- patch
- weight
- styrene
- base material
- kneaded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Medicinal Preparation (AREA)
Description
本発明は貼付薬の製造法に関するものであつ
て、さらに詳しくはハツカゴム膏とパツプ剤の中
間の粘着力を有する貼付薬の製造法に係る。
従来の貼付薬を大別すると、生ゴム、軟化剤、
粘着性付与樹脂及び充填剤を含有する混合物に、
膏体主薬を配合し、この組成物を支持体上に塗布
展延して製造される所謂ハツカゴム膏と、ゼラチ
ンなどの水溶性高分子化合物に保湿剤、カオリ
ン、水及び膏体主薬を配合した混練物を支持体上
に塗布展延して製造される所謂パツプ剤とに分類
される。
このうち前者のハツカゴム膏は、膏体基材に生
ゴムを使用している関係で、特異体質の人にこれ
を貼付した場合には、生ゴム中の不純物(タンパ
ク質など)に起因して、アレルギー症状が現われ
ることがあり、また普通体質の人にあつても、比
較的粘着力が強いため濃く発毛した部位に貼付し
た場合には剥離時に苦痛を伴い、そうした部位で
なくても同一部位に繰返し貼付した場合には、剥
離に際して当該部位の表皮が損傷される虞れもあ
る。こうした使用上の欠陥に加えて、ハツカゴム
膏は生ゴムの素練りから始まる一連の膏体基材調
製工程が複雑多岐に亘り、これにかかる経費が生
産コストの主要部分を占める点でも不利を免れな
い。
これに対してパツプ剤は、その粘着力が一般に
弱いため、剥離に際してはハツカゴム膏で経験さ
れるような苦痛などを殆ど伴わない。しかし、こ
のものは使用中に含有水分が揮散するにつれて粘
着力が急激に低下するので剥脱しやすく、使用部
位によつてはパツプ剤の四隅を粘着テープなどで
固定する必要が生ずるという致命的な欠点があつ
た。
本発明は特殊な合成高分子化合物を膏体基材に
利用した新しい貼付薬の製造法を提案するもので
あつて、本発明の方法で製造される貼付薬は、特
殊な膏体基材を使用しているが故に、特異体質の
人に貼付してもアレルギー症状の発現を心配する
要がなく、また粘着力も穏当であるため、使用に
際してはハツカゴム膏やパツプ剤で問題とされる
如き欠陥がない。
本発明に係る貼付薬の製造法は、スチレン/イ
ソプレン/スチレンのブロツク共重合体(A)又はス
チレン/ブタジエン/スチレンのブロツク共重合
体(B)メチルメタクリレートをグラフト重合させた
変性共重合体からなる膏体基材と、流動パラフイ
ンと、粘着性付与樹脂と充填剤を含有する混合物
に、膏体主薬を配合して混練し、その混練物を支
持体上に塗布展延することからなる。
本発明に於て膏体基材として使用されるブロツ
ク共重合体の変性物は結晶相からなるセグメント
(スチレン)と無定形相からなるセグメント(イ
ソプレン又はブタジエン)を含有し、加温すれば
流動性を生じ、冷却すれば半固体に硬化して粘弾
性を呈する熱可塑性合成ゴムである。ちなみに、
当該合成ゴムの弾性モジユラスは200%伸長時で
0.08〜0.8Kg/cm2の値を示す。以下SISと略記する
スチレン/イソプレン/スチレンのブロツク共重
合体(A)は、カリフレツクスTR1107なる商品名
(シエル化学株式会社製)で、一方、SBSと略記
するスチレン/ブタジエン/スチレンのブロツク
共重合体(B)は、カリフレツクスTR1101又は
TR1102なる商品名(同上)で共に市場から入手
可能である。そしてSIS−MMA乃至SBS−
MMAと略記される本発明の変性共重合体は、上
記したSIS又はSBSに放射線重合法でメチルメタ
クリレート(MMA)をグラフト重合させたもの
であつて、一般にはSIS又はSBS90〜95重量部に
MMAを10〜5重量部の割合でグラフト重合させ
たものを可とする。膏体基材としてはSIS−
MMA及びSBS−MMAの1種もしくは2種以上
が使用可能であるが、膏体基材の量はこれに流動
パラフイン、粘着性付与樹脂及び充填剤などを加
えた混合物の20〜45重量%であることが好まし
い。
軟化剤には従来のハツカゴム膏で使用されたポ
リブテン、プロセスオイル以外に、本発明では流
動パラフインが使用されるが配合量は従前通りで
ある。粘着性付与剤、充填剤及び膏体主薬には、
従来当業界で使用されて来たものがあり従来通り
の配合量で使用される。例えば粘着性付与樹脂と
してはポリテルペン樹脂(例:ys−レジン)、直
鎖炭化水素樹脂(例:エスコレツツ)、水添ロジ
ンエステル(例:エステルガム)などが、また充
填剤としては亜鉛華又は二酸化チタンなどの白色
顔料が、膏体主薬としてはサリチル酸メチル、サ
リチル酸グリコール、カンフル、l−メントー
ル、トウガラシ(エキス)、キヤプサイシン、ノ
ニル酸ワニリルアミド、副腎皮質ホルモン乃至は
皮膚保護薬などが従前通りの配合量で使用され
る。
本発明の貼付薬は膏体基材として特殊な合成高
分子化合物を使用している関係で、界面活性剤の
存在下に3〜20重量%の水を配合することができ
る。水の配合によつて貼付薬はその皮膚刺激性が
増強されるので、皮膚血流量を促進する効果を発
揮する。この場合の界面活性剤としては、ソルビ
タンモノオレート、ソルビタンモノステアレート
又はポリオキシエチレンアリルアルコールエステ
ルなどを可とし、その使用量は1.5〜15.0重量%
の範囲とすることが好ましい。そしてプロピレン
グリコール、グリセリンで例示される保湿剤の併
用が推奨される。尚、念のため付言すると、生ゴ
ムを膏体基材とする従来の貼付薬では、これに水
を配合した例がない。
本発明の貼付薬と従来のハツカゴム膏及びパツ
プ剤との比較を表−1に示す。
The present invention relates to a method for producing a patch, and more particularly to a method for producing a patch having an adhesive strength between that of a patch and a poultice. Conventional patch medicines can be roughly divided into raw rubber, softeners,
a mixture containing a tackifying resin and a filler;
A so-called balm paste is produced by applying and spreading this composition on a support, and a water-soluble polymer compound such as gelatin is blended with a humectant, kaolin, water, and a paste base. It is classified as a so-called poultice, which is produced by coating and spreading a kneaded product on a support. Among these, the former type, Hatsuka rubber plaster, uses raw rubber as the base material, so if it is applied to a person with an idiosyncratic constitution, it may cause allergic symptoms due to impurities (proteins, etc.) in the raw rubber. Even if you have a normal constitution, the adhesive is relatively strong, so if you apply it to an area with thick hair, it will be painful to remove it, and even if it is not such an area, you may be able to repeatedly apply it to the same area. If it is pasted, there is a risk that the epidermis of the area will be damaged when it is removed. In addition to these drawbacks in use, Hatsuka rubber plaster is also disadvantageous in that the series of steps for preparing the base material, starting from mastication of raw rubber, are complex and varied, and the costs associated with this process account for a major portion of the production cost. . On the other hand, poultices generally have weak adhesive strength, so when peeled off, the pain experienced with adhesive plasters is hardly felt. However, as the moisture content evaporates during use, the adhesive strength of this poultice rapidly decreases, causing it to easily peel off, and depending on the area where it is used, the four corners of the poultice may need to be fixed with adhesive tape, which is a fatal problem. There were flaws. The present invention proposes a new method for producing a patch that uses a special synthetic polymer compound as a plaster base material. Because it is used, there is no need to worry about developing allergic symptoms even if it is applied to people with idiosyncratic constitutions, and the adhesive strength is moderate, so when using it, there is no need to worry about the problems that occur with adhesive plasters and poultices. There is no. The method for producing the patch according to the present invention is to prepare a styrene/isoprene/styrene block copolymer (A) or a styrene/butadiene/styrene block copolymer (B) from a modified copolymer obtained by graft polymerization of methyl methacrylate. A paste base material is mixed with a mixture containing a paste base material, liquid paraffin, a tackifying resin, and a filler, and the paste base agent is mixed and kneaded, and the kneaded product is coated and spread on a support. The modified block copolymer used as the plaster base material in the present invention contains a segment consisting of a crystalline phase (styrene) and a segment consisting of an amorphous phase (isoprene or butadiene), and it flows when heated. It is a thermoplastic synthetic rubber that exhibits viscoelasticity and hardens into a semi-solid upon cooling. By the way,
The elastic modulus of the synthetic rubber is at 200% elongation.
Indicates a value of 0.08-0.8Kg/ cm2 . The styrene/isoprene/styrene block copolymer (A), hereinafter abbreviated as SIS, has a trade name of Califrex TR1107 (manufactured by Siel Chemical Co., Ltd.), while the styrene/butadiene/styrene block copolymer (A), abbreviated as SBS, (B) is Califlex TR1101 or
Both are available on the market under the trade name TR1102 (same as above). And SIS-MMA to SBS-
The modified copolymer of the present invention, abbreviated as MMA, is obtained by graft-polymerizing methyl methacrylate (MMA) onto the above-mentioned SIS or SBS using a radiation polymerization method, and generally contains 90 to 95 parts by weight of SIS or SBS.
A material obtained by graft polymerization of MMA in a proportion of 10 to 5 parts by weight is acceptable. SIS- as a plaster base material
One or more types of MMA and SBS-MMA can be used, but the amount of the plaster base material is 20 to 45% by weight of the mixture containing liquid paraffin, tackifier resin, filler, etc. It is preferable that there be. In addition to the polybutene and process oil used in conventional adhesive plasters, liquid paraffin is used as a softening agent in the present invention, but the amount used is the same as before. Tackifiers, fillers and base ingredients include:
There are some that have been conventionally used in this industry, and they are used in conventional amounts. For example, tackifying resins include polyterpene resins (e.g. YS-resin), linear hydrocarbon resins (e.g. Escorets), hydrogenated rosin esters (e.g. ester gum), and fillers include zinc white or dioxide. White pigments such as titanium are used as base ingredients for the paste, such as methyl salicylate, glycol salicylate, camphor, l-menthol, capsicum (extract), capsaicin, nonylic acid vanillylamide, adrenocortical hormones, and skin protection agents in the same amount as before. used in Since the adhesive patch of the present invention uses a special synthetic polymer compound as a base material, 3 to 20% by weight of water can be blended in the presence of a surfactant. By adding water, the skin irritation of the patch is enhanced, so it exhibits the effect of promoting skin blood flow. In this case, the surfactant may be sorbitan monooleate, sorbitan monostearate, polyoxyethylene allyl alcohol ester, etc., and the amount used is 1.5 to 15.0% by weight.
It is preferable to set it as the range of. It is also recommended to use humectants such as propylene glycol and glycerin. It should be noted that there are no examples of conventional adhesive patches that use raw rubber as a base material to include water. Table 1 shows a comparison between the adhesive patch of the present invention and conventional adhesive plasters and poultices.
【表】
進んで本発明の実施例を示す。
実施例 1
表−2に示す配合割合で膏体基材(SIS−
MMA、SBS−MMA)と軟化剤(流動パラフイ
ン)と充填剤(二酸化チタン)を加熱加圧式混練
機で均質に混合し、これに粘着性付与樹脂(エス
テルガム)を加え、さらに膏体主薬を配合して温
度100℃前後の混練物を得た。この混練物をスフ
モス、不織布などからなる支持体に塗布展延後、
任意のサイズに裁断して本発明の貼付薬を製造し
た。
尚、SIS及びSBSにはそれぞれ既述のカリフレ
ツクスTR1107及びTR1101を使用し、また貼付
薬表面にはセロハン、ポリエチレン又はポリプロ
ピレンのフイルム、剥離紙などを貼り付けた。[Table] Examples of the present invention will now be shown. Example 1 Plaster base material (SIS-
MMA, SBS-MMA), a softener (liquid paraffin), and a filler (titanium dioxide) are homogeneously mixed in a heating and pressure kneading machine, and a tackifier resin (ester gum) is added to this, followed by the base agent for the paste. A kneaded product having a temperature of around 100°C was obtained by blending. After coating and spreading this kneaded material on a support made of sfumos, nonwoven fabric, etc.
The adhesive patch of the present invention was manufactured by cutting it into an arbitrary size. Note that the above-mentioned Califrex TR1107 and TR1101 were used for the SIS and SBS, respectively, and cellophane, polyethylene or polypropylene film, release paper, etc. were pasted on the surface of the patch.
【表】
実施例 2
本例は含水貼付薬の製造例を示すものであつ
て、表−3の配合割合で膏体基材(SIS−MMA、
SBS−MMA)と流動パラフインの25重量%相当
分と二酸化チタンを加圧加熱式混練機に収めてま
ず混合し、これに流動パラフインの70重量%相当
分を加えて混練した。一方、流動パラフインの残
り(5重量%相当分)と水とプロピレングリコー
ルとグリセリンと界面活性剤を表−3に示す割合
で混合して乳化液を調製し、この乳化液を前記の
混練物と混合した。次いでこの混合物に膏体基材
を配合して混練物を得、以後実施例1と同一の手
順で含水貼付薬を得た。[Table] Example 2 This example shows an example of manufacturing a water-containing patch, in which plaster base materials (SIS-MMA, SIS-MMA,
SBS-MMA), liquid paraffin equivalent to 25% by weight, and titanium dioxide were placed in a pressurized and heated kneader and mixed together, and to this was added liquid paraffin equivalent to 70% by weight and kneaded. On the other hand, an emulsion was prepared by mixing the remaining liquid paraffin (equivalent to 5% by weight), water, propylene glycol, glycerin, and a surfactant in the proportions shown in Table 3, and this emulsion was mixed with the above-mentioned kneaded material. Mixed. Next, a paste base material was added to this mixture to obtain a kneaded product, and thereafter a water-containing patch was obtained in the same manner as in Example 1.
Claims (1)
共重合体(A)又はスチレン/ブタジエン/スチレン
のブロツク共重合体(B)にメチルメタクリレートを
グラフト重合させた変性共重合体からなる膏体基
材と、流動パラフインと、粘着性付与樹脂と充填
剤を含有する混合物に、膏体主薬を配合して均質
に混練し、その混練物を支持体上に塗布展延する
ことからなる貼付薬の製造法。 2 前記の混合物中の膏体基材量を20〜45重量%
とする特許請求の範囲第1項記載の貼付薬の製造
法。 3 前記の混練物中に、ソルビタンモノオレー
ト、ソルビタンモノステアレート及びポリオキシ
エチレンステアリルアルコールエーテルから選ば
れる界面活性剤を1.5〜15.0重量%、水分を3〜
20重量%配合する特許請求の範囲第1項又は第2
項記載の貼付薬の製造法。 4 前記の混練物中に保湿剤をさらに配合する特
許請求の範囲第3項記載の貼付薬の製造法。[Claims] 1. A plaster made of a modified copolymer obtained by graft polymerizing methyl methacrylate to a styrene/isoprene/styrene block copolymer (A) or a styrene/butadiene/styrene block copolymer (B). A patch drug consisting of a mixture containing a base material, liquid paraffin, a tackifying resin, and a filler, mixed with a paste base agent and kneaded homogeneously, and the kneaded product is spread on a support. manufacturing method. 2 The amount of plaster base material in the above mixture is 20 to 45% by weight.
A method for manufacturing a patch medicine according to claim 1. 3 In the above kneaded material, 1.5 to 15.0% by weight of a surfactant selected from sorbitan monooleate, sorbitan monostearate, and polyoxyethylene stearyl alcohol ether, and 3 to 3% of water.
Claim 1 or 2 containing 20% by weight
Method for manufacturing patch medicines described in Section 1. 4. The method for producing a patch according to claim 3, wherein a humectant is further added to the kneaded product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9700679A JPS5620515A (en) | 1979-07-30 | 1979-07-30 | Preparation of plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9700679A JPS5620515A (en) | 1979-07-30 | 1979-07-30 | Preparation of plaster |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5620515A JPS5620515A (en) | 1981-02-26 |
| JPS6340766B2 true JPS6340766B2 (en) | 1988-08-12 |
Family
ID=14180157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9700679A Granted JPS5620515A (en) | 1979-07-30 | 1979-07-30 | Preparation of plaster |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5620515A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0277552U (en) * | 1988-11-30 | 1990-06-14 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993004677A1 (en) * | 1991-08-30 | 1993-03-18 | Hisamitsu Pharmaceutical Co., Inc. | Anti-inflammatory analgesic plaster |
| DE3331892C2 (en) * | 1983-09-03 | 1986-01-23 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Transport and storage containers for radioactive material |
| JPS6468316A (en) * | 1987-09-08 | 1989-03-14 | Teikoku Seiyaku Kk | External plaster containing salbutamol |
| DE3933460A1 (en) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | OSTROGEN-ACTIVE PLASTER |
| JPH08319234A (en) * | 1995-05-24 | 1996-12-03 | Yuutoku Yakuhin Kogyo Kk | Percutaneous absorption type antiinflammatory and analgesic plaster |
| JP4812268B2 (en) * | 2004-08-03 | 2011-11-09 | リンテック株式会社 | Volatilization inhibitor, volatile component-containing composition and patch |
| BR112017012615B1 (en) | 2014-12-18 | 2021-04-06 | L'oreal | COMPOSITION AND SKIN ENRICHMENT FILM, AND METHOD TO IMPROVE SKIN APPEARANCE |
| US10835479B2 (en) * | 2015-12-31 | 2020-11-17 | L'oreal | Systems and methods for improving the appearance of the skin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6034922B2 (en) * | 1978-09-01 | 1985-08-12 | 久光製薬株式会社 | New patch medicine |
| JPS55133310A (en) * | 1979-04-03 | 1980-10-17 | Hisamitsu Pharmaceut Co Inc | Novel paste tape and its production |
| JPS55141408A (en) * | 1979-04-19 | 1980-11-05 | Hisamitsu Pharmaceut Co Inc | Novel plaster containing steroid and its production |
-
1979
- 1979-07-30 JP JP9700679A patent/JPS5620515A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0277552U (en) * | 1988-11-30 | 1990-06-14 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5620515A (en) | 1981-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3007368C2 (en) | ||
| KR950013461B1 (en) | Fransdermal multipolymer drug delivery system | |
| CA2066249C (en) | Estradiol percutaneous administration preparations | |
| JPH08509748A (en) | Transdermal therapeutic system containing estradiol | |
| WO2002032431A1 (en) | Compositions for external preparations | |
| JPH11512080A (en) | A transdermal therapeutic system for delivering an active substance to the human body through the skin | |
| KR20020011964A (en) | Sheet-form adhesive preparation | |
| JPS6340766B2 (en) | ||
| TW493995B (en) | Plasticizer and cataplasm containing the same | |
| JPS5936608A (en) | Novel application drug | |
| JP2504415B2 (en) | Nitro plaster | |
| JPS6034924B2 (en) | Poultice and its manufacturing method | |
| JPH0723306B2 (en) | New patch preparation | |
| JP3525272B2 (en) | Skin sticking sheet | |
| JPS61260014A (en) | Base for hydrous patch | |
| JPH04368314A (en) | Patch | |
| JPH06145050A (en) | Method of manufacturing patch | |
| JPS59104314A (en) | Novel plaster | |
| JPH0331162B2 (en) | ||
| JPS6258332B2 (en) | ||
| JPH0466451B2 (en) | ||
| JPH0436132B2 (en) | ||
| JPS61267512A (en) | Laminated structure | |
| JPH06145047A (en) | Hydrous skin patch for external use having improved utility | |
| JPH0566150B2 (en) |